PULMONX CORPORATION (LUNG) Return on equity 2020–2025
PULMONX CORPORATION (LUNG) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-99.8%FY2025 · since FY2020: -14.3% → -99.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -99.8% | -34.1 pp |
| FY2024 | -65.7% | -14.3 pp |
| FY2023 | -51.4% | -13.2 pp |
| FY2022 | -38.3% | -13.1 pp |
| FY2021 | -25.2% | -10.9 pp |
| FY2020 | -14.3% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice